Racial variation in semen quality is not well studied in reproductive medicine. Recent estimates suggest that genetic abnormalities (including chromosome abnormalities and single gene mutations) contribute to 15% of male factor infertility.
specimens from Black/African American and Asian men. There was a significant decrease in TMSC in specimens from Asian men compared to specimens from White men (β= -15.4, p=0.0045), as well as in specimens from Black/African American men as compared to specimens from White men (β=-16.18, p=0.0293), but no difference between specimens from Black/African American and Asian men.
Conclusions:
Significant progress has been made in personalized reproductive medicine as advances in next generation sequencing have enabled us to make individualized treatment recommendations based on patient genotypes. Inherent to personalized medicine is the ability to leverage phenotypic and genotypic information, including detailed information about race, to develop predictive models and treatment recommendations. Our study was the largest to date to evaluate racial variations in sperm quality in a non-infertile population of males presenting for sperm donation. Confirming the preliminary findings of the Study for Future Families, 2 we found that specimens from Black/African American men had significantly lower TMSC when compared to those from White men; however, we found no difference in semen volume or SC. We also demonstrated significant differences in SA parameters of Asian men when compared to White men. While self-reported race provides some clues to patient origin, using ancestry informative markers (AIMs) based on genetic/genomic data will be more precise. Further efforts in sequencing donors may elucidate polymorphisms that are more prevalent in men of different races, providing even greater insight into differential expression of gene pathways regulating spermatogenesis. 
